The methylation status of a subset of 33 breast cancers (6 luminal A-like, 6 luminal B-like, 5 HER2-enriched, and 16 basal-like) was established through examination of methylation-sensitive biomarker gene expression. Here, ERBB2 is linked to breast carcinoma.